Zobrazeno 1 - 10
of 15
pro vyhledávání: '"P. Monika Verdouw"'
Autor:
Elise J. Heesbeen, Elisabeth Y. Bijlsma, P. Monika Verdouw, Caspar van Lissa, Carlijn Hooijmans, Lucianne Groenink
Publikováno v:
Psychopharmacology.
Rationale Selective serotonin reuptake inhibitors (SSRIs) are considered first-line medication for anxiety-like disorders such as panic disorder, generalized anxiety disorder, and post-traumatic stress disorder. Fear learning plays an important role
Autor:
Lucianne Groenink, P. Monika Verdouw, Yulong Zhao, Freija ter Heegde, Kimberley E. Wever, Elisabeth Y. Bijlsma
Publikováno v:
Psychopharmacology.
Rationale and objectives Fear conditioning is an important aspect in the pathophysiology of anxiety disorders. The fear-potentiated startle test is based on classical fear conditioning and over the years, a broad range of drugs have been tested in th
Autor:
P Monika, Verdouw, Joantine C J, van Esterik, Bernard W M M, Peeters, Mark J, Millan, Lucianne, Groenink
Publikováno v:
Pharmacology, biochemistry, and behavior. 154
Given the large number of patients that does not respond sufficiently to currently available treatment for anxiety disorders, there is a need for improved treatment.We evaluated the anxiolytic effects of corticotropin releasing factor (CRF)In guinea
Autor:
Jean A. Boutin, P. Monika Verdouw, Marianne Rodriguez, Roberto Maggio, Philippe Vayer, Takashi Yoshitake, Gabriella Aloisi, Catherine de Montrion, Brian P. Lockhart, Mauricette Brocco, Jean-Michel Rivet, Per Svenningsson, Jean-Pierre Galizzi, Lotte De Groote, Benjamin Di Cara, Francis Cogé, Laetitia Cistarelli, Sylvie Veiga, Lucianne Groenink, Ebba Gregorsson Lundius, Millan Mark, Alain Gobert
Publikováno v:
The Journal of Neuroscience. 31:16928-16940
“Ecstasy” [3,4-methylenedioxymetamphetamine (MDMA)] is of considerable interest in light of its prosocial properties and risks associated with widespread recreational use. Recently, it was found to bind trace amine-1 receptors (TA1Rs), which modu
Autor:
Millan Mark, Marijke de Graaff, P. Monika Verdouw, Lucianne Groenink, Anneloes Dirks, Berend Olivier, Bernard W.M.M. Peeters
Publikováno v:
Biological Psychiatry, 63, 4, pp. 360-368
Biological Psychiatry, 63, 360-368
Biological Psychiatry, 63, 360-368
Background Both corticotropin-releasing factor (CRF) and glucocorticoid receptors (GR) are implicated in the psychotic symptoms of psychiatric disorders. Correspondingly, it is of interest to determine their respective involvement in the sensorimotor
Autor:
Lucianne Groenink, Jocelien D A Olivier, Mark A. Geyer, Berend Olivier, Jan van der Gugten, P. Monika Verdouw, Anneloes Dirks, Koen G.C. Westphal
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 28(10), 1790-1798. Nature Publishing Group
Neuropsychopharmacology, 28, 1790-8
Neuropsychopharmacology, 28, 10, pp. 1790-8
Neuropsychopharmacology, 28, 1790-8
Neuropsychopharmacology, 28, 10, pp. 1790-8
Item does not contain fulltext Chronically elevated levels of corticotropin-releasing factor (CRF) in transgenic mice overexpressing CRF in the brain (CRF-OE) appear to be associated with alterations commonly associated with major depressive disorder
Publikováno v:
Current Protocols in Pharmacology
Described in this unit is the ultrasonic distress vocalization test in rat pups. This test is a reliable method for detecting anxiolytic properties of test compounds. In this test, ultrasonic vocalizations (30 to 50 kHz) are elicited by separating ra
Autor:
Lucianne Groenink, Jan G. Veening, Jan van der Gugten, P. Monika Verdouw, Anneloes Dirks, Marlies lutje Schipholt, Berend Olivier
Publikováno v:
Biological Psychiatry, 51, 11, pp. 875-81
Biological Psychiatry, 51, 875-81
Biological Psychiatry, 51, 875-81
Item does not contain fulltext BACKGROUND: Hypersecretion of corticotropin-releasing hormone (CRH) in the brain has been implicated in stress-related human pathologies. We developed a transgenic mouse line overexpressing CRH (CRH-OE) exclusively in n
Publikováno v:
European journal of pharmacology. 280(2)
The effects of flesinoxan, a selective 5-HT1A receptor agonist, were studied under basal non-stress conditions and in the shock-probe burying paradigm. Flesinoxan (1 and 3 mg/kg s.c.) significantly reduced burying and freezing behaviour, indicating c
Autor:
Heesbeen, Elise J.1 (AUTHOR), Bijlsma, Elisabeth Y.1 (AUTHOR), Verdouw, P. Monika1 (AUTHOR), van Lissa, Caspar2 (AUTHOR), Hooijmans, Carlijn3 (AUTHOR), Groenink, Lucianne1 (AUTHOR) l.groenink@uu.nl
Publikováno v:
Psychopharmacology. Nov2023, Vol. 240 Issue 11, p2335-2359. 25p.